title: Guideline on the requirements of external quality assessment programs in molecular pathology.
abstract: Molecular pathology is an integral part of daily diagnostic pathology and used for classification of tumors, for prediction of prognosis and response to therapy, and to support treatment decisions. For these reasons, analyses in molecular pathology must be highly reliable and hence external quality assessment (EQA) programs are called for. Several EQA programs exist to which laboratories can subscribe, but they vary in scope, number of subscribers, and execution. The guideline presented in this paper has been developed with the purpose to harmonize EQA in molecular pathology. It presents recommendations on how an EQA program should be organized, provides criteria for a reference laboratory, proposes requirements for EQA test samples, and defines the number of samples needed for an EQA program. Furthermore, a system for scoring of the results is proposed as well as measures to be taken for poorly performing laboratories. Proposals are made regarding the content requirements of an EQA report and how its results should be communicated. Finally, the need for an EQA database and a participant manual are elaborated. It is the intention of this guideline to improve EQA for molecular pathology in order to provide more reliable molecular analyses as well as optimal information regarding patient selection for treatment.
authors.affiliation: Department of Pathology 824, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands. J.vanKrieken@pathol.umcn.nl
authors.forename: J Han
authors.initials: JH
authors.lastname: van Krieken
authors.forename: Nicola
authors.initials: N
authors.lastname: Normanno
authors.forename: Fiona
authors.initials: F
authors.lastname: Blackhall
authors.forename: Elke
authors.initials: E
authors.lastname: Boone
authors.forename: Gerardo
authors.initials: G
authors.lastname: Botti
authors.forename: Fatima
authors.initials: F
authors.lastname: Carneiro
authors.forename: Ilhan
authors.initials: I
authors.lastname: Celik
authors.forename: Fortunato
authors.initials: F
authors.lastname: Ciardiello
authors.forename: Ian A
authors.initials: IA
authors.lastname: Cree
authors.forename: Zandra C
authors.initials: ZC
authors.lastname: Deans
authors.forename: Anders
authors.initials: A
authors.lastname: Edsjö
authors.forename: Patricia J T A
authors.initials: PJ
authors.lastname: Groenen
authors.forename: Outi
authors.initials: O
authors.lastname: Kamarainen
authors.forename: Hans H
authors.initials: HH
authors.lastname: Kreipe
authors.forename: Marjolijn J L
authors.initials: MJ
authors.lastname: Ligtenberg
authors.forename: Antonio
authors.initials: A
authors.lastname: Marchetti
authors.forename: Samuel
authors.initials: S
authors.lastname: Murray
authors.forename: Frank J M
authors.initials: FJ
authors.lastname: Opdam
authors.forename: Scott D
authors.initials: SD
authors.lastname: Patterson
authors.forename: Simon
authors.initials: S
authors.lastname: Patton
authors.forename: Carmine
authors.initials: C
authors.lastname: Pinto
authors.forename: Etienne
authors.initials: E
authors.lastname: Rouleau
authors.forename: Ed
authors.initials: E
authors.lastname: Schuuring
authors.forename: Silke
authors.initials: S
authors.lastname: Sterck
authors.forename: Miquel
authors.initials: M
authors.lastname: Taron
authors.forename: Sabine
authors.initials: S
authors.lastname: Tejpar
authors.forename: Wim
authors.initials: W
authors.lastname: Timens
authors.forename: Erik
authors.initials: E
authors.lastname: Thunnissen
authors.forename: Peter M
authors.initials: PM
authors.lastname: van de Ven
authors.forename: Albert G
authors.initials: AG
authors.lastname: Siebers
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Dequeker
mesh_terms: D019411:Clinical Laboratory Techniques / Q000592:standards*; D005104:Expert Testimony; D006801:Humans; D057089:Pathology, Molecular / Q000592:standards*; D011785:Quality Assurance, Health Care